Cisplatin or not in advanced gastric cancer: a systematic review and meta-analysis.
<h4>Background</h4>Cisplatin-based chemotherapy is frequently used to treat advanced gastric cancer (GC). Although it leads to increased overall survival (OS) when added to single agents or chemotherapy doublets, toxicity is also generally increased. The purpose of this meta-analysis stu...
Saved in:
| Main Authors: | Fausto Petrelli, Alberto Zaniboni, Andrea Coinu, Mary Cabiddu, Mara Ghilardi, Giovanni Sgroi, Sandro Barni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0083022&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Docetaxel, cisplatin and fluorouracil (DCF) regimen compared with non-taxane-containing palliative chemotherapy for gastric carcinoma: a systematic review and meta-analysis.
by: Xiao-Long Chen, et al.
Published: (2013-01-01) -
PATIENT AND DESEASE
by: Sandro Barni
Published: (2024-12-01) -
Irinotecan Plus Mitomycin C as Second-Line Chemotherapy for Advanced Gastric Cancer Resistant to Fluoropyrimidine and Cisplatin: A Retrospective Study
by: Kohei Ogawa, et al.
Published: (2012-01-01) -
Metformin Enhances the Chemosensitivity of Gastric Cancer to Cisplatin by Downregulating Nrf2 Level
by: Guihua Duan, et al.
Published: (2025-01-01) -
Comparing efficacy and safety of weekly vs. triweekly cisplatin concurrently with radiotherapy for locally advanced head and neck cancer: Systematic review and meta-analysis
by: Mohammed Amine Saâd, et al.
Published: (2025-06-01)